NLRP3 and metabolic dysfunction-associated steatohepatitis: NLRP3, a pivotal biomarker of NASH, drives pyroptosis in primary hepatocytes derived from murine and human sources upon activation, accompanied by the release of NLRP3 inflammasome-associated proteins.